Status:
ACTIVE_NOT_RECRUITING
Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Copenhagen University Hospital, Denmark
Conditions:
Oropharynx Cancer
Oropharynx Cancer, Metastatic
Eligibility:
All Genders
18+ years
Brief Summary
This study investigates if longitudinal analyses of cell-free HPV-DNA in blood samples can be utilized to detect recurrence in patients diagnosed and treated for HPV-positive oropharyngeal squamous ce...
Eligibility Criteria
Inclusion
- Patients with newly diagnosed HPV+ (and/or p16+) oropharyngeal squamous cell carcinoma
- Above 18 years of age
- Informed consent
Exclusion
- The patient does not speak or understand Danish
- patients recieving palliative treatment
Key Trial Info
Start Date :
April 2 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06592716
Start Date
April 2 2024
End Date
December 31 2028
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Otorhinolaryngology, Head and Neck Surgery and Audiology
Copenhagen, Denmark